Connect Biopharma Holdings (CNTB) Invested Capital (2020 - 2022)

Connect Biopharma Holdings (CNTB) has reported Invested Capital for 3 consecutive years, with $421531.0 the latest figure, recorded in Q4 2022.

• Quarterly Invested Capital rose 239.85% year-over-year to $421531.0 in Q4 2022, while the trailing twelve-month figure through Mar 2024 was $421531.0 (changed N/A YoY) and the FY2022 annual result came in at $421531.0, up 239.85% from the prior year.
• Invested Capital advanced to $421531.0 in Q4 2022 per CNTB's latest filing, from $124032.8 in the prior quarter.
• Over the last five years, Invested Capital for CNTB reached as high as $312.6 million in Q4 2020 and fell as low as $124032.8 in Q4 2021.
• A 3-year average of $104.4 million and a median of $421531.0 in 2022 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2021 — Invested Capital slumped 99.96% — and 2022, when it surged 239.85%.
• Year by year, Invested Capital stood at $312.6 million in 2020, then sank by 99.96% to $124032.8 in 2021, then jumped by 239.85% to $421531.0 in 2022.
• According to Business Quant data, Invested Capital over the past three periods registered $421531.0, $124032.8, and $312.6 million for Q4 2022, Q4 2021, and Q4 2020 respectively.